Elexacaftor/ Tezacaftor/Ivacaftor Induced Rash and Subsequent Desensitization in a Paediatric Patient with Cystic Fibrosis

被引：0
|
作者：
Renwick, C. [1 ]
Xing, C. [1 ]
Harris, V [1 ,2 ]
Price, A. [1 ,2 ]
St Pierre, K. [1 ]
Fleischer, E. [1 ]
Rieder, M. J. [1 ,2 ]
Del Pozzo-Magana, B. [1 ,2 ]
机构：
[1] London Hlth Sci Ctr, Childrens Hosp, London, ON, Canada
[2] Western Univ, Dept Paediat, London, ON, Canada
来源：
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2023年 / 76卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：165 / 165
页数：1
相关论文
共 50 条
  • [21] Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis
    Casey, Michelle
    Gabillard-Lefort, Claudie
    McElvaney, Oisin F.
    McElvaney, Oliver J.
    Carroll, Tomas
    Heeney, Ronan C.
    Gunaratnam, Cedric
    Reeves, Emer P.
    Murphy, Mark P.
    McElvaney, Noel G.
    THORAX, 2023, 78 (08) : 835 - 839
  • [22] Elexacaftor/tezacaftor/ivacaftor corrects monocyte microbicidal deficiency in cystic fibrosis
    Cavinato, Luca
    Luly, Francesco R.
    Pastore, Valentina
    Chiappetta, Daniele
    Sangiorgi, Gloria
    Ferrara, Eva
    Baiocchi, Pia
    Mandarello, Giuseppe
    Cimino, Giuseppe
    Del Porto, Paola
    Ascenzioni, Fiorentina
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (04)
  • [23] Characterization of sleep in emerging adults with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor
    Meltzer, Lisa J.
    Gross, Jane E.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (01) : 132 - 136
  • [24] Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease
    Djavid, Amir Reza
    Thompson, Alison E.
    Irace, Alexandria L.
    Gusman, Elen
    Altman, Kimberly
    DiMango, Emily A.
    Keating, Claire L.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (11) : 1924 - 1927
  • [25] Elexacaftor-tezacaftor-ivacaftor overdose in an adolescent female with cystic fibrosis
    Lyman, Benjamin C.
    Seay, Jessica
    Contreary, Casey
    Savant, Adrienne P.
    Dell, Mary Lynn
    Hescock, George C.
    PEDIATRIC PULMONOLOGY, 2022, 57 (12) : 3174 - 3176
  • [26] Effects of elexacaftor/tezacaftor/ivacaftor on liver fibrosis markers in adults with cystic fibrosis
    Tewkesbury, Daniel H.
    Scott, Jennifer
    Barry, Peter J.
    Bright-Thomas, Rowland J.
    Hanley, Karen Piper
    Athwal, Varinder
    Jones, Andrew M.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (02) : 349 - 353
  • [27] EFFECTS OF ELEXACAFTOR/ TEZACAFTOR/ IVACAFTOR ON MARKERS OF LIVER FIBROSIS IN ADULTS WITH CYSTIC FIBROSIS
    Portolese, Olivia
    Bilodeau, Marc
    Castel, Helene
    Willems, Bernard E.
    Huard, Genevieve
    Vincent, Catherine
    Lavoie, Annick
    Hercun, Julian
    HEPATOLOGY, 2023, 78 : S638 - S639
  • [28] Characteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor/tezacaftor/ivacaftor
    Sanders, Don B.
    Mayer-Hamblett, Nicole
    Rosenfeld, Margaret
    Polinieni, Deepika
    Dasenbrook, Elliott
    Szczesniak, Rhonda
    Cromwell, Elizabeth A.
    JOURNAL OF CYSTIC FIBROSIS, 2025, 24 (02) : 255 - 262
  • [29] Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis
    Stapleton, Amanda L.
    Kimple, Adam J.
    Goralski, Jennifer L.
    Nouraie, S. Mehdi
    Branstetter, Barton F.
    Shaffer, Amber
    Pilewski, Joseph M.
    Senior, Brent A.
    Lee, Stella E.
    Zemke, Anna C.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (05) : 792 - 799
  • [30] The impact of elexacaftor/tezacaftor/ivacaftor on adherence to maintenance therapies in cystic fibrosis
    Johnson, Ellie
    Land, Rachel
    Reid, David
    RESPIROLOGY, 2024, 29 : 7 - 7
12345